Literature DB >> 28783257

Biogenesis of circular RNAs and their roles in cardiovascular development and pathology.

Mengyang Li1, Wei Ding2, Teng Sun1, Muhammad A Tariq1, Tao Xu1, Peifeng Li1, Jianxun Wang1.   

Abstract

Circular RNAs (circRNAs) are a newly discovered type of RNA generated by back-splicing of precursor mRNA and found in many species. They are, expressed in a tissue-specific manner and fulfill regulatory activities in many biological processes. Recent research has revealed that circRNAs play critical roles in the development and pathologies of the cardiovascular system. Some of these circRNAs show aberrant expression and regulatory activities during heart disease including heart failure and cardiac infarction and hypertrophy. These findings suggest that circRNAs might be a suitable target for the treatment and prevention of heart disease. In this review, we summarize the latest research on the biogenesis and functions of circRNAs with emphasis on the regulatory roles of circRNAs in the development and pathologies of the cardiovascular system.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  cardiovascular development; cardiovascular diseases; cardiovascular system; circular RNA

Mesh:

Substances:

Year:  2017        PMID: 28783257     DOI: 10.1111/febs.14191

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  43 in total

Review 1.  Noncoding RNAs in the Regulatory Network of Hypertension.

Authors:  Gengze Wu; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 2.  Follistatin-like 1 and its paralogs in heart development and cardiovascular disease.

Authors:  Martin Horak; DeLisa Fairweather; Piia Kokkonen; David Bednar; Julie Bienertova-Vasku
Journal:  Heart Fail Rev       Date:  2022-07-22       Impact factor: 4.654

Review 3.  Use of Circular RNAs in Diagnosis, Prognosis and Therapeutics of Renal Cell Carcinoma.

Authors:  Rebeca Osca-Verdegal; Jesús Beltrán-García; José Luis Górriz; José María Martínez Jabaloyas; Federico V Pallardó; José Luis García-Giménez
Journal:  Front Cell Dev Biol       Date:  2022-06-22

4.  Altered expression of circular RNAs in human placental chorionic plate-derived mesenchymal stem cells pretreated with hypoxia.

Authors:  Xunsha Sun; Yulin Jin; Qihua Liang; Jie Tang; Jinsong Chen; Qiuxia Yu; Fatao Li; Yan Li; Jieying Wu; Shaoqing Wu
Journal:  J Clin Lab Anal       Date:  2018-11-28       Impact factor: 2.352

Review 5.  Non-coding RNAs as biomarkers for acute myocardial infarction.

Authors:  Chen Wang; Qing Jing
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

Review 6.  Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases.

Authors:  Ahmed S Bayoumi; Tatsuya Aonuma; Jian-Peng Teoh; Yao-Liang Tang; Il-Man Kim
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

7.  Potential role of circular RNA in cyclosporin A-induced cardiotoxicity in rats.

Authors:  Yanru Zhao; Yang Li; Dachuan Fan; Jinxiao Hou; Yunpeng Bai; Chenguang Dai; Xue Cao; Hai Qi; Bingchen Liu
Journal:  J Appl Toxicol       Date:  2021-05-25       Impact factor: 3.628

8.  Circ_0068655 Promotes Cardiomyocyte Apoptosis via miR-498/PAWR Axis.

Authors:  Qiaoying Chai; Mingqi Zheng; Le Wang; Mei Wei; Yajuan Yin; Fangfang Ma; Xinping Li; Haijun Zhang; Gang Liu
Journal:  Tissue Eng Regen Med       Date:  2020-08-06       Impact factor: 4.169

Review 9.  Noncoding RNAs in doxorubicin-induced cardiotoxicity and their potential as biomarkers and therapeutic targets.

Authors:  Hong-Ge Fa; Wen-Guang Chang; Xue-Juan Zhang; Dan-Dan Xiao; Jian-Xun Wang
Journal:  Acta Pharmacol Sin       Date:  2020-07-21       Impact factor: 6.150

10.  hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.

Authors:  Xuezuo Sui; Yanchun Wang; Hui Liu
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.